Results 101 to 110 of about 1,807,811 (158)

Inhibition of a live-attenuated chlamydia oral vaccine in the large intestine is dependent on CD11c-expressing cells that produce IL-23. [PDF]

Sci Rep
He Y, Abdelsalam AM, Wu Y, Rodroguez M, Fan H, Zhong G.   +5 more
europepmc   +1 more source

A Novel Probiotic-Based Oral Vaccine against SARS-CoV-2 Omicron Variant B.1.1.529. [PDF]

Int J Mol Sci, 2023
Chau ECT, Kwong TC, Pang CK, Chan LT, Chan AML, Yao X, Tam JSL, Chan SW, Leung GPH, Tai WCS, Kwan YW.   +10 more
europepmc   +1 more source

Immunostimulatory Pickering emulsion for oral vaccine delivery. [PDF]

Int J Pharm
Xie J, Li X, Funk GA, Song SJ, Shah U, Ahlquist CS, Kim H.   +6 more
europepmc   +1 more source

Oral manifestations caused by the linear IgA disease

, 2004
La enfermedad por depósito lineal de IgA o enfermedad IgA lineal (EAL) es un proceso mucocutaneo crónico e infrecuente de origen autoinmune, caracterizado por depósitos lineales de IgA a lo largo de la membrana basal.
Martínez-Sahuquillo Márquez, Ángel
core  

Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations. [PDF]

Front Immunol
Coria LM, Pueblas Castro C, Bruno L, Nakaya HI, Pasquevich KA, Cassataro J.   +5 more
europepmc   +1 more source

The efficacy of new oral vaccine feeds against Salmonid novirhabdovirus in rainbow trout. [PDF]

Fish Shellfish Immunol Rep, 2023
Gorgoglione B, Liu JT, Li J, Vakharia VN.   +3 more
europepmc   +1 more source

Correction: Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations. [PDF]

Front Immunol
Coria LM, Pueblas Castro C, Bruno L, Nakaya HI, Pasquevich KA, Cassataro J.   +5 more
europepmc   +1 more source

Use of Nanostructured Silica SBA-15 as an Oral Vaccine Adjuvant to Control Mycoplasma hyopneumoniae in Swine Production. [PDF]

Int J Mol Sci, 2023
Storino GY, Petri FAM, Mechler-Dreibi ML, Aguiar GA, Toledo LT, Arruda LP, Malcher CS, Martins TS, Montassier HJ, Sant'Anna OA, Fantini MCA, de Oliveira LG.   +11 more
europepmc   +1 more source

Leveraging polysaccharide-derived nanocarriers to open new horizons in oral vaccine activation. [PDF]

Mater Today Bio
Wang S, Jiang T, Jiang M, Miao YB.
europepmc   +1 more source

Targeted delivery of oral vaccine antigens to aminopeptidase N protects pigs against pathogenic E. coli challenge infection. [PDF]

Front Immunol, 2023
Van der Weken H, Jahantigh HR, Cox E, Devriendt B.   +3 more
europepmc   +1 more source